Details of the Drug
General Information of Drug (ID: DMR9IE5)
| Drug Name |
EEC
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
N-[3-(3-Phenylisoxazol-5-Yl)propanoyl]-L-Alpha-Glutamyl-L-Alpha-Glutamyl-Amide; SCHEMBL14122610; CHEMBL1232489; BDBM120166; US8691753, 14; N-[3-(3-phenyl-1,2-oxazol-5-yl)propanoyl]-L-alpha-glutamyl-L-alpha-glutamine; EEC
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Structure |
![]() |
|||||
| 3D MOL | 2D MOL | |||||
| #Ro5 Violations (Lipinski): 1 | Molecular Weight (mw) | 474.5 | ||||
| Logarithm of the Partition Coefficient (xlogp) | -0.4 | |||||
| Rotatable Bond Count (rotbonds) | 14 | |||||
| Hydrogen Bond Donor Count (hbonddonor) | 5 | |||||
| Hydrogen Bond Acceptor Count (hbondacc) | 9 | |||||
| Chemical Identifiers |
|
|||||
| Cross-matching ID | ||||||
| Drug-Molecule Activity Atlas (DMA)NEW | Click to Jump to the Detailed DMA Information of This Drug | |||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||


